Zuo Z, Li Y, Zeng C, Xi Y, Tao H, Guo Y. Integrated analyses identify key molecules and reveal the potential mechanism of miR-182-5p/FOXO1 axis in alcoholic liver disease. Front Med (Lausanne). 2021;8:767584.
Zhao L, Mehmood A, Yuan D, Usman M, Murtaza MA, Yaqoob S, et al. Protective mechanism of edible food plants against alcoholic liver disease with special mention to polyphenolic compounds. Nutrients. 2021;13(5):1612.
Article CAS PubMed PubMed Central Google Scholar
Nagaoki Y, Hyogo H, Ando Y, Kosaka Y, Uchikawa S, Nishida Y, et al. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. BMC Gastroenterol. 2021;21(1):306.
Article PubMed PubMed Central Google Scholar
Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA. 2021;326(2):165–76.
Article CAS PubMed Google Scholar
Yang YM, Cho YE, Hwang S. Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. Int J Mol Sci. 2022;23(2):774.
Article CAS PubMed PubMed Central Google Scholar
Namachivayam A, Valsala GA. A review on molecular mechanism of alcoholic liver disease. Life Sci. 2021;274:119328.
Article CAS PubMed Google Scholar
Park JW, Kim SE, Lee NY, Kim JH, Jung JH, Jang MK, et al. Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases. Int J Mol Sci. 2021;23(1):426.
Article PubMed PubMed Central Google Scholar
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113(2):175–94.
Article PubMed PubMed Central Google Scholar
Wang L, Kong L, Xu S, Wang X, Huang K, Wang S, et al. Isoliquiritigenin-mediated miR-23a-3p inhibition activates PGC-1α to alleviate alcoholic liver injury. Phytomedicine. 2022;96:153845.
Article CAS PubMed Google Scholar
Lieber SR, Rice JP, Lucey MR, Bataller R. Controversies in clinical trials for alcoholic hepatitis. J Hepatol. 2018;68(3):586–92.
Fu K, Wang C, Ma C, Zhou H, Li Y. The potential application of chinese medicine in liver diseases: A new opportunity. Front Pharmacol. 2021;12:771459.
Article CAS PubMed PubMed Central Google Scholar
Caputo F, Domenicali M, Bernardi M. Diagnosis and treatment of alcohol use disorder in patients with End-Stage alcoholic liver disease. Hepatology. 2019;70(1):410–7.
Cao H, Xi S, He W, Ma X, Liu L, Xu J, et al. The effects of Gentiana dahurica Fisch on alcoholic liver disease revealed by RNA sequencing. J Ethnopharmacol. 2021;279:113422.
Article CAS PubMed Google Scholar
Zhu YW, Li D, Ye TJ, Qiu FJ, Wang XL, Yan XF, et al. The study of Yin-Chen-Hao-Tang preventing and treating alcoholic fatty liver disease through PPAR signaling pathway based on network pharmacology and RNA-Seq transcriptomics. Evid Based Complement Alternat Med. 2021;2021:8917993.
Article PubMed PubMed Central Google Scholar
Zhu Z, Zhou W, Yang Y, Wang K, Li F, Dang Y. Quantitative profiling of oxylipin reveals the mechanism of Pien-Tze-Huang on alcoholic liver disease. Evid Based Complement Alternat Med. 2021;2021:9931542.
PubMed PubMed Central Google Scholar
Feng Q, Huang Z, Su L, Fan Y, Guan Y, Zhang G. Therapeutic efficacy and safety of Yinzhihuang granules with phototherapy in neonatal pathologic jaundice: an updated systematic review and meta-analysis. Phytomedicine. 2022;100:154051.
Article CAS PubMed Google Scholar
Wu FF, Huang C, Lin MJ, Wang L, Xu K, Zhou X. Effect of acupressure combined with Yinzhihuang granules on neonatal jaundice: a systematic review and meta-analysis of randomized controlled trials. Transl Pediatr. 2022;11(2):219–28.
Article PubMed PubMed Central Google Scholar
Zhang J, Liu X, Zhou W, Cheng G, Wu J, Guo S, et al. A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification. Sci Rep. 2020;10(1):11448.
Article CAS PubMed PubMed Central Google Scholar
Zhang F, Luo XJ, Zhang ZL. Effect of Yinzhihuang Granules combined with Silibinin Capsules on clinical efficacy and liver function-related indexes in patients with alcoholic liver disease. Guizhou Med J. 2020;44(12):1958–9.
Yang XP, Jang LL. Efficacy observation of Yinzhihuang granules combined with silibinin capsules in the treatment of alcoholic liver disease. Drugs Clin. 2019;34(03):701–4.
Ran B, Guo CE, Li W, Li W, Wang Q, Qian J, et al. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota. J Sci Food Agric. 2021;101(7):2846–54.
Article CAS PubMed Google Scholar
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.
Article PubMed PubMed Central Google Scholar
Song W, Hao Z. Network pharmacology study of yuebi plus banxia decoction in treating asthma. World J Tradit Chin Med. 2021;7(03):370–6.
Li C, Pan J, Xu C, Jin Z, Chen X. A preliminary inquiry into the potential mechanism of Huang-Lian-Jie-Du decoction in treating rheumatoid arthritis via network pharmacology and molecular docking. Front Cell Dev Biol. 2021;9:740266.
Zhao F, Liu S, Gao Q, Zhang J, Du G, Wang F, et al. Network pharmacology-based study of chinese herbal qixiong formula in treating oligoasthenospermia. World J Tradit Chin Med. 2020;6(04):481–9.
Ihlenfeldt WD, Bolton EE, Bryant SH. The PubChem chemical structure sketcher. J Cheminform. 2009;1(1):20.
Article PubMed PubMed Central Google Scholar
Daina A, Michielin O, Zoete V. Swisstargetprediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357–64.
Article CAS PubMed PubMed Central Google Scholar
Safran M, Dalah I, Alexander J, Rosen N, Iny ST, Shmoish M, et al. GeneCards version 3: the human gene integrator. Database (Oxford). 2010;2010:q20.
Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45(D1):D833–9.
Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789-98.
Gao Q, Zhang W, Li T, Yang G, Zhu W, Chen N, et al. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network. Sci Rep. 2022;12(1):188.
Article CAS PubMed PubMed Central Google Scholar
Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. Jvenn: An interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293.
Article PubMed PubMed Central Google Scholar
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–12.
Article CAS PubMed Google Scholar
Yao Q, He YL, Wang N, Dong SS, Tu HTMS, Feng X, et al. Identification of potential genomic alterations and the circRNA-miRNA-mRNA regulatory network in primary and recurrent synovial sarcomas. Front Mol Biosci. 2021;8:707151.
Article CAS PubMed PubMed Central Google Scholar
Liu XS, Zhou LM, Yuan LL, Gao Y, Kui XY, Liu XY, et al. NPM1 is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and associated with m6A modification and glycolysis. Front Immunol. 2021;12:724741.
Article CAS PubMed PubMed Central Google Scholar
Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow GV, et al. RCSB protein data bank: celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D. Protein Sci. 2022;31(1):187–208.
Article CAS PubMed Google Scholar
Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010;24(5):417–22.
留言 (0)